Arkolith/Insider Trading/AURA/Form 4

de los Pinos Elisabet

See Remarks, DirectorAura Biosciences, Inc. (AURA) · full profile →Form 4 · filed Oct 29, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$57K
Net Open-Market Flow
-$57K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Oct 29, 2025Sell(S)9K$6.35$57K474K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-25-256619) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML